| Name | KRAS G13D peptide, 25 mer |
|---|
| Description | KRAS G13D peptide, 25 mer, a KRAS activating oncogene mutation peptide, is an immune potentiator extracted from patent WO2018144775A1. KRAS G13D peptide, 25 mer can be used to prepare KRAS vaccine[1]. |
|---|---|
| Related Catalog | |
| In Vitro | KRAS G13D peptide, 25 mer is encoded by immunomodulatory therapeutic mRNA that can be used to prepare KRAS vaccine[1]. |
| References |
| Molecular Formula | C118H201N29O36S |
|---|---|
| Molecular Weight | 2634.10 |